title: Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.
abstract: Quebec platelet disorder (QPD) is an inherited bleeding disorder associated with increased urokinase plasminogen activator (uPA) in platelets but not in plasma, intraplatelet plasmin generation, and alpha-granule protein degradation. These abnormalities led us to investigate uPA expression by QPD CD34(+) progenitors, cultured megakaryocytes, and platelets, and whether uPA was stored in QPD alpha-granules. Although QPD CD34(+) progenitors expressed normal amounts of uPA, their differentiation into megakaryocytes abnormally increased expression of the uPA gene but not the flanking genes for vinculin or calcium/calmodulin-dependent protein kinase IIgamma on chromosome 10. The increased uPA production by cultured QPD megakaryocytes mirrored their production of alpha-granule proteins, which was normal. uPA was localized to QPD alpha-granules and it showed extensive colocalization with alpha-granule proteins in both cultured QPD megakaryocytes and platelets, and with plasminogen in QPD platelets. In QPD megakaryocytes, cultured without or with plasma as a source of plasminogen, alpha-granule proteins were stored undegraded and this was associated with much less uPA-plasminogen colocalization than in QPD platelets. Our studies indicate that the overexpression of uPA in QPD emerges with megakaryocyte differentiation, without altering the expression of flanking genes, and that uPA is costored with alpha-granule proteins prior to their proteolysis in QPD.
authors.affiliation: Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON, Canada.
authors.forename: D Kika
authors.initials: DK
authors.lastname: Veljkovic
authors.forename: Georges E
authors.initials: GE
authors.lastname: Rivard
authors.forename: Maria
authors.initials: M
authors.lastname: Diamandis
authors.forename: Jessica
authors.initials: J
authors.lastname: Blavignac
authors.forename: Elisabeth M
authors.initials: EM
authors.lastname: Cramer-Bordé
authors.forename: Catherine P M
authors.initials: CP
authors.lastname: Hayward
mesh_terms: D018952:Antigens, CD34 / Q000378:metabolism; D001791:Blood Platelet Disorders / Q000473:pathology* / Q000503:physiopathology*; D001792:Blood Platelets / Q000166:cytology / Q000502:physiology; D002454:Cell Differentiation / Q000502:physiology; D002478:Cells, Cultured; D015870:Gene Expression / Q000502:physiology; D006801:Humans; D055016:Megakaryocyte Progenitor Cells / Q000166:cytology* / Q000502:physiology*; D010958:Plasminogen / Q000378:metabolism; D034061:Thrombopoiesis / Q000502:physiology; D014568:Urokinase-Type Plasminogen Activator / Q000235:genetics* / Q000378:metabolism
chemical_list: D018952:Antigens, CD34; D010958:Plasminogen; D014568:Urokinase-Type Plasminogen Activator